Literature DB >> 20310039

Hydroxyapatite versus titanium implant: Comparison of the functional outcome after vocal fold medialization in unilateral recurrent nerve paralysis.

Claudio Storck1, Claude Fischer, Mikis Cecon, Stephan Schmid, Franco Gambazzi, Markus Wolfensberger, Meike Brockmann.   

Abstract

BACKGROUND: Results of medialization thyroplasty for treatment of unilateral vocal fold paralysis are often unsatisfactory. This study compares glottal closure and voice quality after use of 2 different medialization implant types: VoCoM and TVFMI.
METHODS: In all, 26 patients with unilateral vocal fold paralysis following thoracic surgery underwent medialization thyroplasty. In 11 patients (group I), a hydroxyapatite implant (VoCoM) was used. In 15 patients (group II), a titanium implant (TVFMI) was used. Preoperative and postoperative glottal closure and voice function were assessed with videostroboscopy, perceptual and objective voice measures, and the Voice Dysfunction Index (VDI).
RESULTS: Group II showed a higher rate of complete glottal closure and greater improvement in perceived hoarseness, maximal phonation time, and maximal voice intensity than those in group I.
CONCLUSIONS: With the individually adjustable titanium implant, better glottal closure and better functional outcome (phonation time and voice quality) were achieved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20310039     DOI: 10.1002/hed.21370

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  [Treatment of recurrent laryngeal nerve paralysis].

Authors:  A H Müller
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

2.  Learning curve of medialization thyroplasty using a Montgomery™ implant.

Authors:  G Desuter; S Henrard; D Boucquey; M Van Boven; Q Gardiner; M Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-24       Impact factor: 2.503

3.  Long-term results after external vocal fold medialization thyroplasty with titanium vocal fold medialization implant (TVFMI).

Authors:  Berit Schneider-Stickler; Johannes Gaechter; Wolfgang Bigenzahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-27       Impact factor: 2.503

4.  Modified thyroplasty for unilateral vocal fold paralysis using an adjustable titanium implant.

Authors:  Wu Wen; Guangbin Sun; Bifeng Sun; Chang Liu; Mingxing Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-13       Impact factor: 2.503

5.  Parameters and Scales Used to Assess and Report Findings From Stroboscopy: A Systematic Review.

Authors:  Heather Shaw Bonilha; Maude Desjardins; Kendrea L Garand; Bonnie Martin-Harris
Journal:  J Voice       Date:  2017-11-02       Impact factor: 2.009

6.  Pre- and intraoperative acoustic and functional assessment of the novel APrevent® VOIS implant during routine medialization thyroplasty.

Authors:  Guan-Yuh Ho; Matthias Leonhard; Doris-Maria Denk-Linnert; Berit Schneider-Stickler
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-16       Impact factor: 2.503

7.  Comparison of the use of silastic with titanium prefabricated implant in type I thyroplasty.

Authors:  Akshat Malik; W V B S Ramalingam; Ajith Nilakantan; Satish Nair; A V Ramesh; Poonam Raj
Journal:  Braz J Otorhinolaryngol       Date:  2014-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.